Risk Factors for Hemoptysis Complicating 17-18 Gauge CT-guided Transthoracic Needle Core Biopsy: Multivariate Analysis of 249 Procedures

Overview

Journal Diagn Interv Radiol

Publisher Galenos Publishing House

Date 2017 Aug 2

PMID 28762333

Citations 7

Authors

Guillaume Chassagnon

Jules Gregory

Marc Al Ahmar

Pierre Magdeleinat

Paul Legmann

Joel Coste

Marie Pierre Revel

Affiliations

Soon will be listed here.

Abstract

Purpose: We aimed to identify modifiable and nonmodifiable risk factors for hemoptysis complicating computed tomography (CT)-guided transthoracic needle biopsy.

Methods: All procedures performed in our institution from November 2013 to May 2015 were reviewed. Hemoptysis was classified as mild if limited to hemoptoic sputum and abundant otherwise. Presence of intra-alveolar hemorrhage on postbiopsy CT images was also evaluated. Patient- and lesion-related variables were considered nonmodifiable, while procedure-related variables were considered modifiable.

Results: A total of 249 procedures were evaluated. Hemoptysis and alveolar hemorrhage occurred in 18% and 58% of procedures, respectively, and were abundant or significant in 8% and 17% of procedures, respectively. Concordance between the occurrence of significant alveolar hemorrhage (grade ≥2) and hemoptysis was poor (κ=0.28; 95% CI [0.16-0.40]). In multivariate analysis, female gender (P = 0.008), a longer transpulmonary needle path (P = 0.014), and smaller lesion size (P = 0.044) were independent risk factors for hemoptysis. Transpulmonary needle-path length was the only risk factor for abundant hemoptysis with borderline statistical significance (P = 0.049).

Conclusion: The transpulmonary needle path should be as short as possible to reduce the risk of abundant hemoptysis during CT-guided transthoracic needle biopsy.

Citing Articles

Complications of pneumothorax in computed tomography-guided transthoracic needle biopsy and prognostic factors: study on patients with tumor-like lung lesions.

Tran T, Nguyen T, Nguyen V, Vu-Tri T J Thorac Dis. 2024; 16(11):7499-7510.

PMID: 39678840 PMC: 11635216. DOI: 10.21037/jtd-24-955.

Diagnostic yield and complication rates of percutaneous transthoracic CT-guided coaxial needle biopsy in persistent pulmonary consolidation.

Wang J, Zhang T, Li H, Hu Y, Xu Y, Huang Z Jpn J Radiol. 2024; 42(11):1305-1314.

PMID: 38937410 DOI: 10.1007/s11604-024-01623-2.

Comparison of CT-Guided Core Needle Biopsy in Pulmonary Ground-Glass and Solid Nodules Based on Propensity Score Matching Analysis.

An W, Zhang H, Wang B, Zhong F, Wang S, Liao M Technol Cancer Res Treat. 2022; 21:15330338221085357.

PMID: 35297696 PMC: 8935414. DOI: 10.1177/15330338221085357.

Frequency of complications and risk factors associated with computed tomography guided core needle lung biopsies.

Yucel S, Tanrivermis Sayit A, Tomak L, Celenk C Ann Saudi Med. 2021; 41(2):78-85.

PMID: 33818143 PMC: 8020651. DOI: 10.5144/0256-4947.2021.78.

Hemoptysis complicating ultrasound-guided transthoracic needle lung biopsy: air bronchial sign is a risk predictor.

Zhang Y, He L, Zhou X, Zhou D, Tang J, Tang Q J Thorac Dis. 2020; 12(6):3167-3177.

PMID: 32642238 PMC: 7330789. DOI: 10.21037/jtd-20-1247.

References

Gupta S, Krishnamurthy S, Broemeling L, Morello Jr F, Wallace M, Ahrar K . Small (</=2-cm) subpleural pulmonary lesions: short- versus long-needle-path CT-guided Biopsy--comparison of diagnostic yields and complications. Radiology. 2005; 234(2):631-7. DOI: 10.1148/radiol.2342031423. View

Arcila M, Oxnard G, Nafa K, Riely G, Solomon S, Zakowski M . Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay. Clin Cancer Res. 2011; 17(5):1169-80. PMC: 3070951. DOI: 10.1158/1078-0432.CCR-10-2277. View

Aktas A, Gozlek E, Yazkan R, Yilmaz O, Kayan M, Demirtas H . Transthoracic biopsy of lung masses: Non technical factors affecting complication occurrence. Thorac Cancer. 2015; 6(2):151-8. PMC: 4448479. DOI: 10.1111/1759-7714.12156. View

Loh S, Wu D, Venkatesh S, Ong C, Liu E, Seto K . CT-guided thoracic biopsy: evaluating diagnostic yield and complications. Ann Acad Med Singap. 2013; 42(6):285-90. View

MOORE E . Technical aspects of needle aspiration lung biopsy: a personal perspective. Radiology. 1998; 208(2):303-18. DOI: 10.1148/radiology.208.2.9680552. View

Nour-Eldin N, Alsubhi M, Naguib N, Lehnert T, Emam A, Beeres M . Risk factor analysis of pulmonary hemorrhage complicating CT-guided lung biopsy in coaxial and non-coaxial core biopsy techniques in 650 patients. Eur J Radiol. 2014; 83(10):1945-52. DOI: 10.1016/j.ejrad.2014.06.023. View

Ko J, Shepard J, Drucker E, Aquino S, Sharma A, Sabloff B . Factors influencing pneumothorax rate at lung biopsy: are dwell time and angle of pleural puncture contributing factors?. Radiology. 2001; 218(2):491-6. DOI: 10.1148/radiology.218.2.r01fe33491. View

Gupta S, Wallace M, Cardella J, Kundu S, Miller D, Rose S . Quality improvement guidelines for percutaneous needle biopsy. J Vasc Interv Radiol. 2010; 21(7):969-75. DOI: 10.1016/j.jvir.2010.01.011. View

Yildirim E, Kirbas I, Harman A, Ozyer U, Tore H, Aytekin C . CT-guided cutting needle lung biopsy using modified coaxial technique: factors effecting risk of complications. Eur J Radiol. 2008; 70(1):57-60. DOI: 10.1016/j.ejrad.2008.01.006. View

10.

Manhire A, Charig M, Clelland C, Gleeson F, Miller R, Moss H . Guidelines for radiologically guided lung biopsy. Thorax. 2003; 58(11):920-36. PMC: 1746503. DOI: 10.1136/thorax.58.11.920. View

11.

Tai R, Dunne R, Trotman-Dickenson B, Jacobson F, Madan R, Kumamaru K . Frequency and Severity of Pulmonary Hemorrhage in Patients Undergoing Percutaneous CT-guided Transthoracic Lung Biopsy: Single-Institution Experience of 1175 Cases. Radiology. 2015; 279(1):287-96. DOI: 10.1148/radiol.2015150381. View

12.

Chakrabarti B, Earis J, Pandey R, Jones Y, Slaven K, Amin S . Risk assessment of pneumothorax and pulmonary haemorrhage complicating percutaneous co-axial cutting needle lung biopsy. Respir Med. 2008; 103(3):449-55. DOI: 10.1016/j.rmed.2008.09.010. View

13.

Guimaraes M, Marchiori E, Hochhegger B, Chojniak R, Gross J . CT-guided biopsy of lung lesions: defining the best needle option for a specific diagnosis. Clinics (Sao Paulo). 2014; 69(5):335-40. PMC: 4012240. DOI: 10.6061/clinics/2014(05)07. View

14.

Song Y, Park C, Park K, Kim K, Lee H, Shim M . Does antiplatelet therapy increase the risk of hemoptysis during percutaneous transthoracic needle biopsy of a pulmonary lesion?. AJR Am J Roentgenol. 2013; 200(5):1014-9. DOI: 10.2214/AJR.12.8931. View

15.

Lu C, Hsiao C, Chang Y, Lee J, Shih J, Wu L . Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation. J Thorac Oncol. 2011; 7(1):143-50. DOI: 10.1097/JTO.0b013e318233d7dd. View

16.

Laurent F, Montaudon M, Latrabe V, Begueret H . Percutaneous biopsy in lung cancer. Eur J Radiol. 2002; 45(1):60-8. DOI: 10.1016/s0720-048x(02)00286-3. View

17.

Heyer C, Reichelt S, Peters S, Walther J, Muller K, Nicolas V . Computed tomography-navigated transthoracic core biopsy of pulmonary lesions: which factors affect diagnostic yield and complication rates?. Acad Radiol. 2008; 15(8):1017-26. DOI: 10.1016/j.acra.2008.02.018. View

18.

Devesa S, Bray F, Vizcaino A, Parkin D . International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005; 117(2):294-9. DOI: 10.1002/ijc.21183. View

19.

Wang Memoli J, Nietert P, Silvestri G . Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest. 2011; 142(2):385-393. PMC: 3425336. DOI: 10.1378/chest.11-1764. View

20.

Wagnetz U, Menezes R, Boerner S, Paul N, Wagnetz D, Keshavjee S . CT screening for lung cancer: implication of lung biopsy recommendations. AJR Am J Roentgenol. 2012; 198(2):351-8. DOI: 10.2214/AJR.11.6726. View